Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$290K Sell
1,470
-2,904
-66% -$542K 0.04% 82
2024
Q2
$750K Buy
+4,374
New +$725K 0.13% 61
2024
Q1
Sell
-1,546
Closed -$240K 103
2023
Q4
$240K Buy
+1,546
New +$225K 0.08% 94

Other funds holding ABBV

Zega Financial's ABBV Position: Q3 2024 in Review

Zega Financial reduced its AbbVie (ABBV) stake by 66% in Q3 2024, selling an estimated $542K and leaving 1,470 shares worth $290K. The position accounts for 0.04% of the portfolio, ranked #82.

Zega Financial first reported a position in ABBV in Q4 2023 and has held it in 3 quarters since. The position peaked at $750K in Q2 2024. 3,499 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • Zega Financial held 1,470 shares of AbbVie worth $290K as of Q3 2024.
  • Zega Financial sold 2,904 AbbVie shares in Q3 2024, an estimated $542K.
  • AbbVie made up 0.04% of Zega Financial's portfolio in Q3 2024, its #82 holding.
  • Zega Financial first reported a position in AbbVie in Q4 2023 and has held it in 3 quarters since.
  • Zega Financial's AbbVie position peaked at $750K in Q2 2024.
  • 3,499 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Zega Financial's 13F filing for Q3 2024, filed 14 Nov 2024.